As of 2026-07-15, the Relative Valuation of Ikena Oncology Inc (IKNA) is (3.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.43 USD, the upside of Ikena Oncology Inc based on Relative Valuation is -339.0%.
The range of the Relative Valuation is (2.74) - (3.50) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 6.7x - 8.5x | 8.3x |
| Fair Price | (2.74) - (3.50) | (3.42) |
| Upside | -291.8% - -344.8% | -339.0% |
| Date | P/E |